Discussion about this post

User's avatar
NA's avatar

The Fever-Tree chart shows a credible route beyond tonic dependence, but the estimated £193m for 2026 is still a revenue outcome. Distribution costs, promotional spending and incremental margin determine how much reaches shareholders. A broader product mix becomes more valuable when it improves cash generation as well as sales.

No posts

Ready for more?